---
created: '2026-02-09T05:40:22.065484Z'
description: Serine/threonine-protein kinase involved in cell survival, metabolism,
  and growth. Key node in the PI3K-AKT-mTOR signaling pathway.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/protein/akt1/
slug: akt1
tags:
- protein
- kinase
- mtor_pathway
- survival
- metabolic_regulation
templateEngineOverride: njk
title: AKT1
type: protein
updated: '2026-02-09T05:40:22.065484Z'
---

{% raw %}
<h1>AKT1</h1>
<h2>Overview</h2>
<p>AKT1 (RAC-alpha serine/threonine-protein kinase) is a critical signaling node that integrates extracellular signals (growth factors, insulin) to regulate cell survival, growth, and metabolism. It is a core component of the <strong>PI3K-AKT-mTOR pathway</strong>.</p>
<p>Dysregulation of AKT1 is a hallmark of cancer (overactivation promotes survival) and metabolic disorders (underactivation leads to insulin resistance).</p>
<h2>Function</h2>
<ul>
<li><strong>Cell Survival</strong>: Inhibits apoptotic proteins (e.g., BAD, Caspase-9).</li>
<li><strong>Metabolism</strong>: Promotes glucose uptake by translocating GLUT4 to the membrane. Stimulates glycolysis.</li>
<li><strong>Protein Synthesis</strong>: Activates mTORC1 signaling.</li>
<li><strong>Longevity</strong>: Inhibits FOXO transcription factors (which can be pro-aging or anti-aging depending on context, but generally AKT promotes growth over maintenance).</li>
</ul>
<!-- NEO4J_CONTENT_START -->
<h2>Relationships</h2>
<h3>Related</h3>
<ul>
<li>→ [[PI3K-AKT-mTOR_Signaling_Pathway]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:58.404292'
source: obsidian
</code></pre>
<ul>
<li>→ [[Type_2_Diabetes]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:58.404292'
source: obsidian
</code></pre>
<ul>
<li>→ [[Insulin_Signaling_Pathway]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:58.404292'
source: obsidian
</code></pre>
<ul>
<li>→ [[EGFR]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:58.404292'
source: obsidian
</code></pre>
<ul>
<li>← [[Cancer]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:32.664708'
source: obsidian
</code></pre>
<ul>
<li>← [[Insulin]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:19.652699'
source: obsidian
</code></pre>
<ul>
<li>→ [[Type_2_Diabetes]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.530000'
source: obsidian
</code></pre>
<ul>
<li>→ [[Insulin_Signaling_Pathway]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.530000'
source: obsidian
</code></pre>
<ul>
<li>→ [[mTOR]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.530000'
source: obsidian
</code></pre>
<ul>
<li>→ [[GLUT4]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.530000'
source: obsidian
</code></pre>
<ul>
<li>→ [[PI3K-AKT-mTOR_Signaling_Pathway]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.530000'
source: obsidian
</code></pre>
<ul>
<li>→ [[FOXO3]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.530000'
source: obsidian
</code></pre>
<ul>
<li>← [[EGFR]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:30.803713'
source: obsidian
</code></pre>
<ul>
<li>→ [[Cancer]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.530000'
source: obsidian
</code></pre>
<ul>
<li>→ [[Insulin]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.530000'
source: obsidian
</code></pre>
<ul>
<li>← [[TP53]] (protein)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:34.328294'
source: obsidian
</code></pre>
<ul>
<li>← [[CTNNB1]] (protein)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:49:00.223477'
source: obsidian
</code></pre>
<ul>
<li>→ [[CTNNB1]] (protein)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.530000'
source: obsidian
</code></pre>
<ul>
<li>→ [[TP53]] (protein)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:28.530000'
source: obsidian
</code></pre>
<!-- NEO4J_CONTENT_END -->
<h2>Relationships</h2>
<h3>Participates in Pathway</h3>
<ul>
<li>→ [[PI3K-AKT-mTOR Signaling Pathway]] (pathway)</li>
<li>→ [[Insulin Signaling Pathway]] (pathway)</li>
</ul>
<h3>Interacts With</h3>
<ul>
<li>← [[Insulin]] (hormone) - <em>Activates</em></li>
<li>→ [[mTOR]] (protein) - <em>Activates</em></li>
<li>→ [[FOXO3]] (protein) - <em>Inhibits (Phosphorylates)</em></li>
<li>→ [[GLUT4]] (protein) - <em>Translocates</em></li>
<li>→ [[TP53]] (protein)</li>
<li>→ [[CTNNB1]] (protein)</li>
</ul>
<h3>Related Conditions</h3>
<ul>
<li>→ [[Cancer]] (condition) - <em>Overexpression</em></li>
<li>→ [[Type 2 Diabetes]] (condition) - <em>Insulin Resistance</em></li>
</ul>
<h2>References</h2>
<ol>
<li><strong>UniProt</strong>: P31749 (AKT1_HUMAN)</li>
<li><strong>Review</strong>: Manning, B. D., &amp; Toker, A. (2017). &quot;AKT/PKB Signaling: Navigating the Network.&quot; <em>Cell</em>.</li>
</ol>

{% endraw %}